A biomarker panel for acute graft-versus-host diseaseSophie Paczesny, James L.M. Ferrara, John E. Levine et al.|Blood|2008Cited by 404
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survivalSung Won Choi, John E. Levine, Carrie L. Kitko et al.|Blood|2008Cited by 141
Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humansSung Won Choi, Pavan Reddy, Erin Gatza et al.|Blood|2014Cited by 107
Plasma Elevations of Tumor Necrosis Factor-Receptor-1 at Day 7 Postallogeneic Transplant Correlate with Graft-versus-Host Disease Severity and Overall Survival in Pediatric PatientsCarrie L. Kitko, John E. Levine, Sophie Paczesny et al.|Transplantation and Cellular Therapy|2008Cited by 45
Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host DiseaseSophie Paczesny, John E. Levine, Thomas Braun et al.|Blood|2010Cited by 11